STRS Ohio’s AngioDynamics ANGO Stock Holding History

STRS Ohio’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$473K	Hold	41,600	–	–	﹤0.01%	1112
2025 Q4	$534K	Hold	41,600	–	–	﹤0.01%	1043
2025 Q3	$465K	Sell	41,600 -8,300	-17%	-$80.1K	﹤0.01%	1136
2025 Q2	$495K	Sell	49,900 -4,800	-9%	-$47K	﹤0.01%	1312
2025 Q1	$514K	Sell	54,700 -8,500	-13%	-$89.3K	﹤0.01%	1154
2024 Q4	$579K	Sell	63,200 -9,800	-13%	-$72.1K	﹤0.01%	1095
2024 Q3	$568K	Sell	73,000 -13,200	-15%	-$95.3K	﹤0.01%	1180
2024 Q2	$522K	Buy	86,200 +84,700	+5,647%	+$523K	﹤0.01%	1213
2024 Q1	$8K	Sell	1,500 -100	-6%	-$594	﹤0.01%	1887
2023 Q4	$12K	Hold	1,600	–	–	﹤0.01%	1867
2023 Q3	$11K	Buy	+1,600	New	+$13.3K	﹤0.01%	1898
2023 Q1	–	Sell	-10,500	Closed	-$144K	–	1945
2022 Q4	$144K	Hold	10,500	–	–	﹤0.01%	1656
2022 Q3	$214K	Hold	10,500	–	–	﹤0.01%	1587
2022 Q2	$203K	Sell	10,500 -25,600	-71%	-$524K	﹤0.01%	1605
2022 Q1	$777K	Hold	36,100	–	–	﹤0.01%	1196
2021 Q4	$995K	Buy	36,100 +2,800	+8%	+$77.3K	﹤0.01%	1121
2021 Q3	$863K	Sell	33,300 -1,400	-4%	-$37.4K	﹤0.01%	1202
2021 Q2	$941K	Buy	+34,700	New	+$847K	﹤0.01%	1207
2020 Q3	–	Sell	-34,900	Closed	-$354K	–	2188
2020 Q2	$354K	Buy	34,900 +2,500	+8%	+$25.8K	﹤0.01%	1475
2020 Q1	$337K	Hold	32,400	–	–	﹤0.01%	1402
2019 Q4	$518K	Hold	32,400	–	–	﹤0.01%	1430
2019 Q3	$596K	Sell	32,400 -3,600	-10%	-$70.4K	﹤0.01%	1123
2019 Q2	$708K	Buy	36,000 +1,800	+5%	+$36.7K	﹤0.01%	1000
2019 Q1	$781K	Hold	34,200	–	–	﹤0.01%	940
2018 Q4	$688K	Sell	34,200 -900	-3%	-$18.6K	﹤0.01%	965
2018 Q3	$763K	Sell	35,100 -5,500	-14%	-$122K	﹤0.01%	1064
2018 Q2	$902K	Sell	40,600 -5,900	-13%	-$121K	﹤0.01%	955
2018 Q1	$802K	Buy	46,500 +1,400	+3%	+$23.4K	﹤0.01%	1007
2017 Q4	$750K	Buy	45,100 +2,300	+5%	+$39.2K	﹤0.01%	1055
2017 Q3	$731K	Sell	42,800 -2,300	-5%	-$38.6K	﹤0.01%	1115
2017 Q2	$731K	Buy	45,100 +4,600	+11%	+$72.7K	﹤0.01%	1052
2017 Q1	$702K	Sell	40,500 -1,600	-4%	-$26.8K	﹤0.01%	1096
2016 Q4	$710K	Buy	42,100 +3,046	+8%	+$50.8K	﹤0.01%	1103
2016 Q3	$685K	Buy	39,054 +16,354	+72%	+$265K	﹤0.01%	1071
2016 Q2	$326K	Buy	22,700 +9,800	+76%	+$122K	﹤0.01%	1444
2016 Q1	$158K	Buy	+12,900	New	+$143K	﹤0.01%	1558
2015 Q1	–	Sell	-19,600	Closed	-$364K	–	1806
2014 Q4	$373K	Sell	19,600 -7,500	-28%	-$127K	﹤0.01%	1286
2014 Q3	$372K	Sell	27,100 -1,200	-4%	-$17.1K	﹤0.01%	1300
2014 Q2	$462K	Buy	28,300 +27,000	+2,077%	+$391K	﹤0.01%	1246
2014 Q1	$20K	Buy	+1,300	New	+$21.2K	﹤0.01%	1677

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.5M AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

WCM

Weber Capital Management San Francisco, California $100M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

STRS Ohio's ANGO Position: Q1 2026 in Review

STRS Ohio held its AngioDynamics (ANGO) position steady in Q1 2026 at 41,600 shares worth $473K. The position accounts for ﹤0.01% of the portfolio, ranked #1112.

STRS Ohio first reported a position in ANGO in Q1 2014 and has held it in 40 quarters since. The position peaked at $995K in Q4 2021. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

STRS Ohio held 41,600 shares of AngioDynamics worth $473K as of Q1 2026.
STRS Ohio left its AngioDynamics share count unchanged in Q1 2026.
AngioDynamics made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #1112 holding.
STRS Ohio first reported a position in AngioDynamics in Q1 2014 and has held it in 40 quarters since.
STRS Ohio's AngioDynamics position peaked at $995K in Q4 2021.
147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.